Skip to main content

AMGN

Amgen Inc

Company with tickers: AMGN

CIK
318154
CUSIP
031162100
Shares Outstanding
539,708,274
13F Activity (30d)
173 filings 93 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$2,400,000,000
as of 2022-10-31 · not restated in filings since 2023-02-09
Remaining Authorization
$6,800,000,000
as of 2026-03-31

Cash spent on buybacks by quarter

Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2025-12-31 $0
2024-12-31 $200,000,000
2023-12-31 $0
2022-12-31 $6,360,000,000
2021-12-31 $4,975,000,000
2020-12-31 $3,486,000,000
2019-12-31 $7,702,000,000
2018-12-31 $17,794,000,000
2017-12-31 $3,160,000,000
2016-12-31 $2,965,000,000
2015-12-31 $1,867,000,000
2014-12-31 $138,000,000
2013-12-31 $832,000,000
2012-12-31 $4,607,000,000
2011-12-31 $8,315,000,000
2010-12-31 $3,786,000,000
2009-12-31 $3,208,000,000
2008-12-31 $2,268,000,000
2007-12-31 $5,100,000,000